[ad_1]
[앵커]
The AstraZeneca Corona 19 vaccine, which Korea previously purchased in a dose of 10 million people, is expected to be approved for emergency use in the UK within 10 days. If group vaccination begins in the UK in early January next year, vaccination is expected to start in earnest after approval procedures in Korea, the United States and Japan. Reporter Kim Hyung-geun about the report. “The Corona 19 vaccine developed by the University of Oxford in the UK and the pharmaceutical company AstraZeneca may be approved for emergency use from 28 to 29 this month.” The British Daily Telegraph reported this, citing a leading British government source. If the University of Oxford submits the relevant data around the 21st, the UK Medicines and Healthcare Products Regulatory Authority will approve the emergency use around the 28th and 29th. The UK government plans to enter large-scale vaccination from early January next year once its use is approved. The application for approval for the use of the AstraZeneca vaccine has been delayed due to a reliability issue in the results of phase 3 clinical trials. However, it is being evaluated as the most advantageous in the future Corona 19 vaccine competition. The Telegraph predicted that the AstraZeneca vaccine will become a ‘game changer’ that will change the COVID-19 phase. Unlike Pfizer, modders and vaccines that must be distributed at cryogenic temperatures, it is absolutely advantageous for distribution and distribution because it can be stored refrigerated. Also, the price is 5-10 times cheaper than Pfizer, modder or vaccine. Furthermore, it is known to be advantageous for mass production. Because of this, major countries in the United States and Europe also purchased more AstraZeneca vaccines than Pfizer, Modena, or vaccines. The Korean government has also signed a contract to supply 10 million doses. In particular, in Korea, SK Bioscience consigns the production of vaccines against AstraZeneca. Therefore, the news of the imminent approval of the AstraZeneca vaccine is good news for Korea, which is awaiting the supply of the vaccine. This is YTN Kim Hyung-geun.
